uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary
Ctr Nacl Invest Cardiovasc, Melchor Fernandez Almagro 3, Madrid 28029, Spain;Hosp Univ 12 Octubre, Cardiol Dept, Madrid, Spain;Univ Complutense Madrid, Madrid, Spain.
Univ Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands;Dutch Med Evaluat Board, Utrecht, Netherlands.
Bristol Myers Squibb, Rueil Malmaison, France.
Univ Paris 05, Cochin Hotel Dieu Hosp, French Natl Agcy Med & Hlth Prod Safety, Paris, France.
Show others and affiliations
2019 (English)In: European heart journal. Acute cardiovascular care., ISSN 2048-8726, Vol. 8, no 8, p. 745-754Article in journal (Refereed) Published
Abstract [en]

Regulatory authorities interpret the results of randomized controlled trials according to published principles. The European Medicines Agency (EMA) is planning a revision of the 2000 and 2003 guidance documents on clinical investigation of new medicinal products for the treatment of acute coronary syndrome (ACS) to achieve consistency with current knowledge in the field. This manuscript summarizes the key output from a collaborative workshop, organized by the Cardiovascular Round Table and the European Affairs Committee of the European Society of Cardiology, involving clinicians, academic researchers, trialists, European and US regulators, and pharmaceutical industry researchers. Specific questions in four key areas were selected as priorities for changes in regulatory guidance: patient selection, endpoints, methodologic issues and issues related to the research for novel agents. Patients with ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) should be studied separately for therapies aimed at the specific pathophysiology of either condition, particularly for treatment of the acute phase, but can be studied together for other treatments, especially long-term therapy. Unstable angina patients should be excluded from acute phase ACS trials. In general, cardiovascular death and reinfarction are recommended for primary efficacy endpoints; other endpoints may be considered if specifically relevant for the therapy under study. New agents or interventions should be tested against a background of evidence-based therapy with expanded follow-up for safety assessment. In conclusion, new guidance documents for randomized controlled trials in ACS should consider changes regarding patient and endpoint selection and definitions, and trial designs. Specific requirements for the evaluation of novel pharmacological therapies need further clarification.

Place, publisher, year, edition, pages
SAGE PUBLICATIONS LTD , 2019. Vol. 8, no 8, p. 745-754
Keywords [en]
Acute coronary syndrome, clinical trials, myocardial infarction, unstable angina, endpoint determination
National Category
Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:uu:diva-400681DOI: 10.1177/2048872616649859ISI: 000501037700009PubMedID: 27357206OAI: oai:DiVA.org:uu-400681DiVA, id: diva2:1382178
Available from: 2020-01-02 Created: 2020-01-02 Last updated: 2020-01-02Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records BETA

James, Stefan

Search in DiVA

By author/editor
Fox, Keith A. A.James, StefanSinnaeve, Peter R.Van de Werf, Frans
By organisation
Cardiology
In the same journal
European heart journal. Acute cardiovascular care.
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 3 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf